My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 277

1.

Coronary vasomotor abnormalities in insulin-resistant individuals.

Quiñones MJ, Hernandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenez X, Hernandez G, De La Rosa R, Chon Y, Yang H, Nicholas SB, Modilevsky T, Yu K, Van Herle K, Castellani LW, Elashoff R, Hsueh WA.

Ann Intern Med. 2004 May 4;140(9):700-8.PMID: 15126253 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Summaries for patients. Insulin resistance is associated with abnormalities of coronary arteries in people without other cardiac risk factors.

[No authors listed]

Ann Intern Med. 2004 May 4;140(9):I32. No abstract available. PMID: 15126271 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.

Prior JO, Quiñones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, Hsueh WA, Schelbert HR.

Circulation. 2005 May 10;111(18):2291-8. Epub 2005 Apr 25.PMID: 15851590 [PubMed - indexed for MEDLINE]Related articlesFree article

4.

Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity.

Campisi R, Czernin J, Schöder H, Sayre JW, Marengo FD, Phelps ME, Schelbert HR.

Circulation. 1998 Jul 14;98(2):119-25.PMID: 9679717 [PubMed - indexed for MEDLINE]Related articlesFree article

5.

Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.

Osei K, Gaillard T, Schuster D.

Metabolism. 2007 Jan;56(1):24-9.PMID: 17161222 [PubMed - indexed for MEDLINE]Related articles

6.

Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients.

Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K.

Heart Vessels. 2008 Jan;23(1):9-15. Epub 2008 Feb 14.PMID: 18273540 [PubMed - indexed for MEDLINE]Related articles

7.

Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study.

Naoumova RP, Kindler H, Leccisotti L, Mongillo M, Khan MT, Neuwirth C, Seed M, Holvoet P, Betteridge J, Camici PG.

J Am Coll Cardiol. 2007 Nov 20;50(21):2051-8. Epub 2007 Nov 5.PMID: 18021872 [PubMed - indexed for MEDLINE]Related articles

8.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.PMID: 15669880 [PubMed - indexed for MEDLINE]Related articles

9.

Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy.

Dimitrow PP, Krzanowski M, Nizankowski R, Szczeklik A, Dubiel JS.

Cardiovasc Drugs Ther. 1999 May;13(3):259-64.PMID: 10439889 [PubMed - indexed for MEDLINE]Related articles

10.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

11.

Early impairment of coronary flow reserve in young men with borderline hypertension.

Laine H, Raitakari OT, Niinikoski H, Pitkänen OP, Iida H, Viikari J, Nuutila P, Knuuti J.

J Am Coll Cardiol. 1998 Jul;32(1):147-53.PMID: 9669263 [PubMed - indexed for MEDLINE]Related articles

12.

Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.

Raji A, Gerhard-Herman MD, Williams JS, O'connor ME, Simonson DC.

Diabet Med. 2006 May;23(5):537-43.PMID: 16681563 [PubMed - indexed for MEDLINE]Related articles

13.

Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes.

Sourij H, Zweiker R, Wascher TC.

Diabetes Care. 2006 May;29(5):1039-45.PMID: 16644634 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function.

Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang XL, Sayre J, Dahlbom M, Licinio J, Schelbert HR.

J Am Coll Cardiol. 2006 Mar 21;47(6):1188-95. Epub 2006 Feb 23.PMID: 16545651 [PubMed - indexed for MEDLINE]Related articles

15.

Coronary flow reserve is reduced in young men with IDDM.

Pitkänen OP, Nuutila P, Raitakari OT, Rönnemaa T, Koskinen PJ, Iida H, Lehtimäki TJ, Laine HK, Takala T, Viikari JS, Knuuti J.

Diabetes. 1998 Feb;47(2):248-54.PMID: 9519721 [PubMed - indexed for MEDLINE]Related articles

16.

Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes.

McMahon GT, Plutzky J, Daher E, Bhattacharyya T, Grunberger G, DiCarli MF.

Diabetes Care. 2005 May;28(5):1145-50.PMID: 15855580 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Obesity affects myocardial vasoreactivity and coronary flow response to insulin.

Sundell J, Laine H, Luotolahti M, Kalliokoski K, Raitakari O, Nuutila P, Knuuti J.

Obes Res. 2002 Jul;10(7):617-24.PMID: 12105283 [PubMed - indexed for MEDLINE]Related articles

18.

Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus.

Hattori N, Schnell O, Bengel FM, Rihl J, Nekolla SG, Drzezga AE, Standl E, Schwaiger M.

Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):891-8. Epub 2002 Apr 24.PMID: 12111129 [PubMed - indexed for MEDLINE]Related articles

19.

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

20.

[Involvement of glucose metabolism abnormalities and insulin resistance in atherosclerotic coronary artery disease: semiquantitative coronary angiography study]

Hikita N, Tsuchihashi K, Nakata T, Ura N, Shimamoto K.

J Cardiol. 1998 Nov;32(5):291-300. Japanese. PMID: 9864685 [PubMed - indexed for MEDLINE]Related articles

Supplemental Content

Filter your results:

Find related data

Recent activity